Skip to main content
Menu
US

HTRF AAV5 Detection Kit, 500 Assay Points

The AAV5 Capsid kit is designed for the quantitative measurement of Adeno-associated virus serotype 5 (AAV5) particles in both cell lysates and cell supernatants.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Part number: 64AAV5PEG
Unit Size: 500 Assay Points
List price: USD 2,207.00
Your price: Login to view
USD 2,207.00
USD 2,207.00 /each
Part number: 64AAV5PEH
Unit Size: 10,000 Assay Points
List price: USD 22,820.00
Your price: Login to view
USD 0.00
USD 22,820.00 /each

Overview

Adeno-associated virus (AA) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases. AAV Serotype 5 (AAV5) has been consistently characterized as the serotype with the lowest seroprevalence and minimal cross reactivity against pre-existing neutralizing antibodies which can be an advantage for its use as a vector for gene therapy of hemophilia A and diseases associated with its natural tissue tropism such as lung, retina, or central nervous system cells. The AAV5 kit is designed to detect and quantify AAV5 particles in an easy-to-use, no-wash format. The simple and robust procedure benefits from increased throughput compared to ELISA.

Specifications

Shipping Conditions
Shipped in Dry Ice
Unit Size
500 Assay Points

Video gallery

How it works

AAV5 Capsid assay principle

The Adeno-Associated Virus serotype 5 (AAV5) assay measures AAV5 capsid in cell supernatant or cell lysate. The assay uses two antibodies anti-AAV5: one labelled with d2 (acceptor) and the other to biotin that binds to Streptavidin Eu-cryptate (donor) in a premix. In presence of AAV5 capsid in a cell extract or supernatant the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor, and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the capsid present in the sample and provides a means of assessing any changes caused by experimental variability under a no-wash assay format.

1assay-principle-aav5-64aav5peg-64aav5peh-64aav5pey.svg

 

AAV5 capsid assay protocol

The AAV5 capsid assay protocol, using a 384-well small volume white plate, is described on the right. 5 µL of sample or standard and 5 µL of diluent are dispensed directly into the detection plate for detection by HTRF® reagents. The Biotin antibody anti-AAV5 was pre-mixed with Streptavidin labeled with donor before being added. The assay can be run in up to a 1536-well format by simply resizing each addition volume proportionally.

2assay-protocol-aav5-64aav5peg-64aav5peh-64aav5pey.svg

 

Assay details

AAV5 capsid assay specifications
Sample size 5 µL
Final assay volume 20 µL
Time to results Overnight at RT
Detection limit (LOD) in diluent 4.48E+08 VP/mL
Dynamic Range 1.49E+09 – 2.50E+11 VP/mL
Sample compatibility

From raw harvest material to the final product

Supernatant, Cell Lysate (LB#3)

 

 

3assay-validation-aav5-64aav5peg-64aav5peh-64aav5pey-full-empty-recognition.svg

Analytical performance

Precision

Intra-assay

 

Sample

Mean [AAV5] (VP/mL)

CV

1

2.00E+11

6%

2

5.00E+10

2%

3

1.25E+10

3%

 

Mean CV

4%

 

 

Each of the 3 samples was measured 24 times, and % CV was calculated for each sample.

Inter-assay

 

Sample

Mean [AAV5] (VP/mL)

CV

1

2.00E+11

7%

2

3.20E+10

8%

3

1.28E+10

11%

 

Mean CV

9%

 

Each of the samples was measured in 3 independent experiments performed by different operators, and the % CV was calculated for each sample.

Dilutional linearity

 

Dilution

Factor

[AAV5] Expected

(VP/mL)

[AAV5] Mesured

(VP/mL)

Dilution Recovery

Neat

-

2.33E+11

100%

2

9.31E+10

8.89E+10

105%

4

3.72E+10

3.76E+10

99%

8

1.49E+10

1.56E+10

96%

16

5.96E+09

6.52E+09

91%

Mean

 

 

98%

 

Interferences

 

[AAV5]

(VP/mL)

[Total Protein]

SF9 cell lysates

Spiked Sample (mg/mL)

Recovery

5.0E+10

0.5

126%

0.25

120%

0.125

122%

0.05

115%

 

 

[AAV5]

(VP/mL)

[Total Protein]

HEK293 cell lysates

Spiked Sample (mg/mL)

Recovery

5.0E+10

0.5

128%

0.25

115%

0.125

109%

0.05

115%

 

 
Antigen Spike and Recovery

 

 

Sample

[AAV5] Standard

(VP/mL)

SF9 cell lysate (0.05 mg/ml)

Recovery

1

2.05E+11

110%

2

5.12E+10

117%

3

1.28E+10

112%

 

Mean CV

113%

 

 

Sample

[AAV5] Standard

(VP/mL)

HEK293 cell lysate (0.25 mg/ml)

Recovery

1

2.05E+11

107%

2

5.12E+10

115%

3

1.28E+10

104%

 

Mean CV

109%

 

 Cross reactivities

 

Empty AAVs Particles

Cross Reactivity

AAV5

100%

AAV1

No

AAV2

No

AAV3B

No

AAV6

No

AAV8

No

AAV9

No

 

 

Assay validation

Validation of HTRF AAV5 capsid detection on full and empty AAV5 particles

To demonstrate the detection of both full and empty AAV5 capsids, recognition of full AAV5-CMV-eGFP and empty AAV5 capsids was analyzed in the assay. A large range of AAV5-CMV-eGFP concentration (GC/mL) was calculated in VP/mL using an independent sample quantitation assay. 5 µL of full or empty capsids diluted in the kit diluent were then transferred into a white detection plate (384 low volume), followed by 5 µL of diluent then 10 µL of the HTRF AAV5 capsid detection reagents. The HTRF signal was recorded after an overnight incubation at room temperature. As expected, the HTRF AAV5 capsid detection assay can detect in the same way both full and empty AAV5 capsids.

4assay-validation-aav5-64aav5peg-64aav5peh-64aav5pey-full-empty-recognition.svg

 

Resources

1-6 of 6 Resources
Whitepaper Icon
Whitepaper
Adeno-Associated Virus (AAV) Vectors Manufacturing

What Are the Challenges and Solutions?

All across the globe, AAVs are getting the attention of scientists and companies working in...

Whitepaper Icon
Whitepaper
Complete gene therapy review in a single industry report

With the increased understanding of molecular and cellular medicine, more specific and efficient gene transfer vectors are now...

Brochure Icon
Brochure
HTRF assays and reagents catalog

Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Whitepaper Icon
Whitepaper
Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases

Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s, are complex disorders that affect millions...

Publication Icon
Literature - Publication Review
Using gene therapy to correct certain genetic disorders

See how researchers boost their gene therapy studies with Revvity technologies

The absence or mutation of protein is a factor that...

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Safety data sheet
+ Show more
Certificate of analysis
+ Show more
IFUs, Manuals & more
Scroll Icon